Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Interest Coverage Ratio (2019 - 2025)

Pulmonx (LUNG) reported Interest Coverage Ratio of 17.88 for Q3 2025, down 12.75% year-over-year from 20.49 in Q3 2024, and up 3.5% on a QoQ basis from 18.53 in Q2 2025.

Pulmonx (LUNG) has 7 years of Interest Coverage Ratio data on file, last reported at 17.88 in Q3 2025.

  • Quarterly Interest Coverage Ratio fell 12.75% year-over-year to 17.88 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 17.72 (down 8.67% YoY) and the FY2024 annual result came in at 16.45, up 14.14% from the prior year.
  • Interest Coverage Ratio improved to 17.88 in Q3 2025 per LUNG's latest filing, from 18.53 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 15.38 in Q4 2023 and bottomed at 79.13 in Q1 2022.
  • The 5-year median for Interest Coverage Ratio is 19.03 (2023), against an average of 34.87.
  • The widest annual swing landed in 2021, when Interest Coverage Ratio slumped 872.64%; it then surged 70.56% in 2023.
  • Tracing LUNG's Interest Coverage Ratio over 5 years: stood at 62.14 in 2021, then soared by 34.43% to 40.74 in 2022, then soared by 62.25% to 15.38 in 2023, then retreated by 3.61% to 15.93 in 2024, then slipped by 12.2% to 17.88 in 2025.
  • Per Business Quant, the three latest LUNG Interest Coverage Ratio figures stand at 17.88 (Q3 2025), 18.53 (Q2 2025), and 18.65 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.73
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.09
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.23
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -2.90
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.36
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 20.98
10 Pulmonx 67.30 Mn -2.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -17.88
Jun 30, 2025 -18.53
Mar 31, 2025 -18.65
Dec 31, 2024 -15.93
Sep 30, 2024 -15.86
Jun 30, 2024 -17.53
Mar 31, 2024 -16.46
Dec 31, 2023 -15.38
Sep 30, 2023 -16.99
Jun 30, 2023 -19.03
Mar 31, 2023 -28.72
Dec 31, 2022 -40.74
Sep 30, 2022 -48.71
Jun 30, 2022 -64.62
Mar 31, 2022 -79.13
Dec 31, 2021 -62.14
Sep 30, 2021 -47.16
Jun 30, 2021 -61.56
Mar 31, 2021 -57.58
Dec 31, 2020 -35.03
Sep 30, 2020 -4.85
Jun 30, 2020 -12.64
Mar 31, 2020 -6.79
Dec 31, 2019 -9.53
Sep 30, 2019 -7.85